Literature DB >> 10684886

Activation of extracellular signal-regulated protein kinases is associated with a sensitized locomotor response to D(2) dopamine receptor stimulation in unilateral 6-hydroxydopamine-lesioned rats.

G Cai1, X Zhen, K Uryu, E Friedman.   

Abstract

Evidence indicates that mitogen-activated protein kinase (MAPK) pathways play a crucial role in the neurobiology of the nervous system. In the present study, dopamine receptor-mediated regulation of extracellular signal-regulated kinases (ERKs) was examined in rats in which the nigrostriatal dopaminergic pathway was unilaterally lesioned by 6-hydroxydopamine (6-OHDA). Subcutaneous injections of the D(2) receptor agonist quinpirole significantly increased tyrosine-phosphorylated ERK1/2 in lesioned striatum, whereas the D(1) receptor agonist SKF38393 failed to activate ERKs. Quinpirole-induced phosphorylation of ERK1/2 was seen as early as 3 min and peaked at 15 min after the challenge. In parallel, striatal ERK kinase activity, measured by the in vitro kinase assay, was increased 2.5-fold on the lesioned side after the administration of quinpirole. Immunohistochemical examination of brain sections after quinpirole administration revealed significant increases in ERK1/2 immunostaining in perinuclear and intranuclear areas of striatal neurons. This increase was much more pronounced on the lesioned than the intact side. Furthermore, quinpirole-induced contralateral rotation was decreased by 48.7 and 50.7%, respectively, when the striatal ERK pathway was selectively inhibited by a single intrastriatal injection of the MAPK/ERK kinase inhibitor PD098059 or after a continuous 7 d intrastriatal infusion of ERK1/2 antisense oligodeoxynucleotide. The results demonstrate, for the first time, that the ERK signaling pathway is activated in denervated striatum in response to stimulation of D(2) dopamine receptors and that the resulting imbalance in striatal ERK activity contributes, at least in part, to neuronal plasticity that underlies D(2) dopamine receptor-mediated contralateral rotation in unilateral 6-OHDA denervated rats.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10684886      PMCID: PMC6772914     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  61 in total

1.  Olfactory learning deficits in mutants for leonardo, a Drosophila gene encoding a 14-3-3 protein.

Authors:  E M Skoulakis; R L Davis
Journal:  Neuron       Date:  1996-11       Impact factor: 17.173

2.  Ras-dependent activation of fibroblast mitogen-activated protein kinase by 5-HT1A receptor via a G protein beta gamma-subunit-initiated pathway.

Authors:  M N Garnovskaya; T van Biesen; B Hawe; S Casañas Ramos; R J Lefkowitz; J R Raymond
Journal:  Biochemistry       Date:  1996-10-29       Impact factor: 3.162

3.  Stabilization of the B-type natriuretic peptide mRNA in cardiac myocytes by alpha-adrenergic receptor activation: potential roles for protein kinase C and mitogen-activated protein kinase.

Authors:  D S Hanford; C C Glembotski
Journal:  Mol Endocrinol       Date:  1996-12

4.  Tyrosine kinases in activation of the MAP kinase cascade by G-protein-coupled receptors.

Authors:  Y Wan; T Kurosaki; X Y Huang
Journal:  Nature       Date:  1996-04-11       Impact factor: 49.962

Review 5.  Anatomy and physiology of the neostriatum.

Authors:  S T Kitai
Journal:  Adv Biochem Psychopharmacol       Date:  1981

6.  The MEKK-JNK pathway is stimulated by alpha1-adrenergic receptor and ras activation and is associated with in vitro and in vivo cardiac hypertrophy.

Authors:  M T Ramirez; V P Sah; X L Zhao; J J Hunter; K R Chien; J H Brown
Journal:  J Biol Chem       Date:  1997-05-30       Impact factor: 5.157

7.  Mechanism of catecholamine-induced proliferation of vascular smooth muscle cells.

Authors:  S M Yu; S Y Tsai; J H Guh; F N Ko; C M Teng; J T Ou
Journal:  Circulation       Date:  1996-08-01       Impact factor: 29.690

8.  RGS4 inhibits Gq-mediated activation of mitogen-activated protein kinase and phosphoinositide synthesis.

Authors:  Y Yan; P P Chi; H R Bourne
Journal:  J Biol Chem       Date:  1997-05-02       Impact factor: 5.157

9.  Lesions of mouse striatum induced by 6-hydroxydopamine differentially alter the density, rate of synthesis, and level of gene expression of D1 and D2 dopamine receptors.

Authors:  Z H Qin; J F Chen; B Weiss
Journal:  J Neurochem       Date:  1994-02       Impact factor: 5.372

10.  Increases in guanine nucleotide binding to striatal G proteins is associated with dopamine receptor supersensitivity.

Authors:  P Butkerait; H Y Wang; E Friedman
Journal:  J Pharmacol Exp Ther       Date:  1994-10       Impact factor: 4.030

View more
  17 in total

1.  Sustained extracellular signal-regulated kinase activation by 6-hydroxydopamine: implications for Parkinson's disease.

Authors:  S M Kulich; C T Chu
Journal:  J Neurochem       Date:  2001-05       Impact factor: 5.372

2.  Impaired D2 dopamine receptor function in mice lacking type 5 adenylyl cyclase.

Authors:  Ko-Woon Lee; Jang-Hee Hong; In Young Choi; Yongzhe Che; Ja-Kyeong Lee; Sung-Don Yang; Chang-Woo Song; Ho Sung Kang; Jae-Heun Lee; Jai Sung Noh; Hee-Sup Shin; Pyung-Lim Han
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

3.  mTORC2/rictor signaling disrupts dopamine-dependent behaviors via defects in striatal dopamine neurotransmission.

Authors:  Olga I Dadalko; Michael Siuta; Amanda Poe; Kevin Erreger; Heinrich J G Matthies; Kevin Niswender; Aurelio Galli
Journal:  J Neurosci       Date:  2015-06-10       Impact factor: 6.167

4.  Synthesis, protein levels, activity, and phosphorylation state of tyrosine hydroxylase in mesoaccumbens and nigrostriatal dopamine pathways of chronically food-restricted rats.

Authors:  Yan Pan; Yemiliya Berman; Sandra Haberny; Emanuel Meller; Kenneth D Carr
Journal:  Brain Res       Date:  2006-09-28       Impact factor: 3.252

5.  Dopaminergic control of sleep-wake states.

Authors:  Kafui Dzirasa; Sidarta Ribeiro; Rui Costa; Lucas M Santos; Shih-Chieh Lin; Andres Grosmark; Tatyana D Sotnikova; Raul R Gainetdinov; Marc G Caron; Miguel A L Nicolelis
Journal:  J Neurosci       Date:  2006-10-11       Impact factor: 6.167

6.  Nitrated alpha-synuclein induces the loss of dopaminergic neurons in the substantia nigra of rats.

Authors:  Zhongwang Yu; Xiaohui Xu; Zhenghua Xiang; Jianfeng Zhou; Zhaohuan Zhang; Chun Hu; Cheng He
Journal:  PLoS One       Date:  2010-04-08       Impact factor: 3.240

7.  D1 dopamine receptor supersensitivity in the dopamine-depleted striatum results from a switch in the regulation of ERK1/2/MAP kinase.

Authors:  Charles R Gerfen; Shigehiro Miyachi; Ronald Paletzki; Pierre Brown
Journal:  J Neurosci       Date:  2002-06-15       Impact factor: 6.167

8.  Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors.

Authors:  Jenny E Westin; Linda Vercammen; Elissa M Strome; Christine Konradi; M Angela Cenci
Journal:  Biol Psychiatry       Date:  2007-07-26       Impact factor: 13.382

9.  Neuroplasticity in brain reward circuitry following a history of ethanol dependence.

Authors:  Anita C Hansson; Roberto Rimondini; Olga Neznanova; Wolfgang H Sommer; Markus Heilig
Journal:  Eur J Neurosci       Date:  2008-04       Impact factor: 3.386

10.  Neurochemical changes in the striatum of dyskinetic rats after administration of the cannabinoid agonist WIN55,212-2.

Authors:  M G Morgese; T Cassano; S Gaetani; T Macheda; L Laconca; P Dipasquale; L Ferraro; T Antonelli; V Cuomo; A Giuffrida
Journal:  Neurochem Int       Date:  2008-11-01       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.